Telaprevir: options of application in separate patient groups
The aim of review. To discuss potential of telaprevir application in patients with the 1-st genotype of chronic hepatitis C (CHC) representing certain difficulties in treatment, in patients having antiviral therapy experience, patients with liver cirrhosis, including, those, enrolled to liver transp...
Saved in:
Main Authors: | M. V. Mayevskaya, I. N. Tikhonov, V. T. Ivashkin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2013-10-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1231 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Triple antiviral therapy in patient with liver cirrhosis: complications and options of pharmacological treatment
by: M. V. Mayevskaya, et al.
Published: (2014-08-01) -
Modern modes of chronic hepatitis C treatment
by: V. T. Ivashkin, et al.
Published: (2012-02-01) -
Efficacy and safety of new protease inhibitor faldaprevir in treatment of hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-12-01) -
RISK FACTORS FOR IMPAIRED BONE DENSITY IN MALE PATIENTS UNDERWENT HEMODIALYSIS DUE TO CHRONIC KIDNEY DISEASE
by: Patritius Kelik Dwi Santo Ismoyo, et al.
Published: (2019-12-01) -
Two ways to one goal: new strategy of antiviral therapy for chronic hepatitis C
by: S. N. Batskikh
Published: (2012-11-01)